| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,089,946 | 334,005 | 2,094,643 | 4,817,672 |
| Prepaid expenses | NaN | NaN | NaN | 374,245 |
| Prepaid expenses and other current assets | 1,373,007 | 168,906 | 1,171,270 | NaN |
| Total current assets | 2,462,953 | 502,911 | 3,265,913 | 5,191,917 |
| Property and equipment, net | 16,311 | 17,319 | 18,327 | 19,335 |
| Intangible assets, net | 9,244,910 | 9,841,242 | NaN | NaN |
| Deferred financing costs | NaN | 12,122 | 30,305 | 48,487 |
| Operating lease right-of-use asset | 85,153 | 102,383 | 228,382 | 244,690 |
| Total assets | 11,809,327 | 10,475,977 | 3,542,927 | 5,504,429 |
| Notes payable to related parties-Related Party | NaN | NaN | NaN | 65,326 |
| Accrued interest payable - related parties-Related Party | NaN | NaN | NaN | 590 |
| Accounts payable and accrued expenses | 1,789,721 | 1,453,770 | 1,472,897 | 1,174,374 |
| Convertible notes payable, net - fair value option-Related Party | NaN | NaN | 139,217 | 127,689 |
| Contingent consideration liability | 2,000,000 | 2,000,000 | NaN | NaN |
| Convertible notes payable, net - fair value option-Nonrelated Party | NaN | NaN | 278,299 | 252,938 |
| Consideration payable | 4,435,927 | 4,435,927 | NaN | NaN |
| Operating lease liability | 79,962 | 77,194 | 74,497 | 71,869 |
| Total current liabilities | 8,305,610 | 7,966,891 | 1,964,910 | 1,692,786 |
| Derivative liability | 23,423 | 99,687 | 8,538 | 10,965 |
| Operating lease liability non-current | 134,051 | 154,953 | 175,318 | 195,159 |
| Total liabilities | 8,463,084 | 8,221,531 | 2,148,766 | 1,898,910 |
| Common stock, 0.00001 par value 100,000,000 shares authorized 5,551,290 shares issued and outstanding at march 31, 2026 2,023,615 shares issued and outstanding at december 31, 2025 | 57 | 20 | 13 | 11 |
| Additional paid in capital | 51,798,427 | 48,554,196 | 45,079,023 | 44,943,081 |
| Accumulated deficit | -48,452,241 | -46,299,770 | -43,684,875 | -41,337,573 |
| Total stockholders equity | 3,346,243 | 2,254,446 | 1,394,161 | 3,605,519 |
| Total liabilities and stockholders equity | 11,809,327 | 10,475,977 | 3,542,927 | 5,504,429 |
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)